Neuland opens first 7,000-litre peptide module after $30 million investment
Module One splits 750 litres of solid-phase and 6,250 litres of liquid-phase capacity, with a second 18,000-litre module already groundworked.
TR
By Tom Reyes · Markets Editor
Sep 16 02:31 ETSource: Chemical Industry Digest
The wire
- 01Neuland Laboratories started operations at Module One of its commercial peptide plant, with three DAC columns and 100-litre and 200-litre lyophilisers supporting multikilogram peptide API and crude peptide output.
- 02Contract capacity for long-chain and complex peptides remains a bottleneck for developers; Neuland says programmes are broadening from obesity and metabolic disease into oncology.
- 03Module Two's timing and configuration depend on an unnamed anchor customer, and the company says further investment will follow demand.
From the source
Read at chemindigest.comNeuland Scales Up Peptide Manufacturing to Meet Rising Demand
Neuland Laboratories is accelerating its peptide manufacturing expansion as the first of four planned modules at its commercial peptide manufacturing facility has now commenced operations. The expansion will strengthen Neuland’s ability to support customers across peptide development and commercial manufacturing. In addition, the company is preparing for the next phase of capacity expansion as cus